CD44 and pancreatic neoplasm: To investigate the functional involvement of TP53INP1, LATS2 and CD44 in pancreatic cancer growth, shRNA-directed knockdown of TP53INP1, LATS2 and CD44 was performed and the effects on cell proliferation, migration and tumour growth were measured.